Vimarsana
Biggest News Aggregation in the World

Page 5 - Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Designation Today - Breaking & Trending Today

Sol-Gel Technologies Ltd to Host Virtual KOL Event on - Vimarsana News

Sol-Gel Technologies Ltd to Host Virtual KOL Event on

Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease...

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610 - Vimarsana News

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610

Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease burden, SGT-610 and the upcoming Phase 3 trial NESS ZIONA, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL) (“Sol-Gel”), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology products, TWYNEO

Source: yahoo.com
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 - Vimarsana News

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

14.11.2023 - LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved ...

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results - Vimarsana News

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

-Advisory Committee meeting for exagamglogene autotemcel (exa-cel) for the treatment of severe sickle cell disease (SCD) completed October 31, 202...

QuantalX Secures Dedicated Reimbursement Code for Delphi-MD Test, Advancing Improved Brain Health - Vimarsana News

QuantalX Secures Dedicated Reimbursement Code for Delphi-MD Test, Advancing Improved Brain Health

/PRNewswire/ -- QuantalX Neuroscience, a pioneering healthcare company dedicated to early detection of brain disorders, is pleased to announce that it has...